Premier Biomedical Inc Stock OTC Bulletin Board
Equities
US74048K1043
Specialty Chemicals
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2018 | 0.04 0.05 | Sales 2019 | 0.01 0.02 | Capitalization | 78.42K 107K |
---|---|---|---|---|---|
Net income 2018 | - 0 | Net income 2019 | - 0 | EV / Sales 2018 | 16,149,039 x |
Net Debt 2018 | 223K 303K | Net Debt 2019 | 89.55K 122K | EV / Sales 2019 | 11,762,132 x |
P/E ratio 2018 |
-0.74
x | P/E ratio 2019 |
-0.06
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Gabe Vlad
DFI | Director of Finance/CFO | - | - |
William Tynan
AUD | Comptroller/Controller/Auditor | - | - |
General Counsel | - | - |
1st Jan change | Capi. | |
---|---|---|
+18.91% | 67.35B | |
-4.17% | 46.44B | |
+23.65% | 44.28B | |
+36.70% | 29.14B | |
+11.45% | 19.48B | |
+14.91% | 17.17B | |
-25.35% | 15.04B | |
-13.27% | 14.72B | |
-29.84% | 12.07B |